Renaissance Investment Consultants Holding Company’s BlackRock Health Sciences Trust BME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
$805K Sell
18,092
-805
-4% -$34.4K 0.75% 29
2020
Q2
$818K Buy
18,897
+161
+0.9% +$6.5K 0.89% 28
2020
Q1
$675K Buy
18,736
+244
+1% +$9.72K 0.94% 27
2019
Q4
$776K Buy
+18,492
New +$733K 0.88% 26

Other funds holding BME

Renaissance Investment Consultants Holding Company's BME Position: Q3 2020 in Review

Renaissance Investment Consultants Holding Company reduced its BlackRock Health Sciences Trust (BME) stake by 4.3% in Q3 2020, selling an estimated $34.4K and leaving 18,092 shares worth $805K. The position accounts for 0.75% of the portfolio, ranked #29.

Renaissance Investment Consultants Holding Company first reported a position in BME in Q4 2019 and has held it in 4 quarters since. The position peaked at $818K in Q2 2020. 47 funds tracked by Wall St. Rank hold BME as of Q3 2020.

  • Renaissance Investment Consultants Holding Company held 18,092 shares of BlackRock Health Sciences Trust worth $805K as of Q3 2020.
  • Renaissance Investment Consultants Holding Company sold 805 BlackRock Health Sciences Trust shares in Q3 2020, an estimated $34.4K.
  • BlackRock Health Sciences Trust made up 0.75% of Renaissance Investment Consultants Holding Company's portfolio in Q3 2020, its #29 holding.
  • Renaissance Investment Consultants Holding Company first reported a position in BlackRock Health Sciences Trust in Q4 2019 and has held it in 4 quarters since.
  • Renaissance Investment Consultants Holding Company's BlackRock Health Sciences Trust position peaked at $818K in Q2 2020.
  • 47 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust as of Q3 2020.

Based on Renaissance Investment Consultants Holding Company's 13F filing for Q3 2020, filed 6 Nov 2020.